23 results
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
21 Mar 24
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
8:00pm
ProKidney in July 2023 as Vice President of Business Development & Innovative Solutions. Prior to joining ProKidney, he was Chief Executive Officer
DEF 14A
PROK
ProKidney Corp - Ordinary Shares
26 May 23
Definitive proxy
8:00am
biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard
424B3
o2l7etk
21 Apr 23
Prospectus supplement
4:18pm
POS AM
fewl75fzxbad12ff79v7
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
424B3
lx5ol 1fkc
9 Sep 22
Prospectus supplement
5:05pm
DEFM14A
8dxu0ow35j
10 Jun 22
Proxy related to merger
4:54pm
DEFA14A
n9gm51937 py4sv4b
19 Jan 22
Additional proxy soliciting materials
4:35pm
DEFA14A
muo7 szptp
18 Jan 22
Additional proxy soliciting materials
5:15pm
424B4
k9pzxl qy8
1 Jul 21
Prospectus supplement with pricing info
5:20pm